Advisor Group Holdings, Inc. Virpax Pharmaceuticals, Inc. Transaction History

Advisor Group Holdings, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$0.24 - $0.82 $432 - $1,476	1,800 Added 300.0%	2,400 $0
Q3 2022 Nov 14, 2022	BUY	$1.15 - $11.9 $505 - $5,236	440 Added 275.0%	600 $1,000
Q1 2022 May 04, 2022	BUY	$1.86 - $3.61 $133 - $259	72 Added 81.82%	160 $0
Q3 2021 Nov 05, 2021	BUY	$4.14 - $22.9 $364 - $2,015	88 New	88 $0
Q2 2021 Aug 02, 2021	SELL	$3.84 - $6.0 $341 - $534	-89 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$4.39 - $6.53 $390 - $581	89 New	89 $0

Ticker VRPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,714,600
Market Cap $7.97M
Description
Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system disorders. Its preclinical stage product candidates include Epoladerm, a topical no...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.